Latest Stories
Xerox (XRX) Stock Is Up, What You Need To Know
Shares of document technology company Xerox (NASDAQ:XRX) jumped 3.7% in the afternoon session after the company announced it had raised $450 million for a new joint venture with global alternative asset management firm TPG and revealed a new global sales structure.
Itron’s (NASDAQ:ITRI) Q4 CY2025 Sales Beat Estimates
Resource management provider Itron (NASDAQ:ITRI) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 6.7% year on year to $571.7 million. On the other hand, next quarter’s revenue guidance of $570 million was less impressive, coming in 1.8% below analysts’ estimates. Its non-GAAP profit of $2.46 per share was 12.4% above analysts’ consensus estimates.
LGI Homes (NASDAQ:LGIH) Misses Q4 CY2025 Revenue Estimates
Affordable single-family home construction company LGI Homes (NASDAQ:LGIH) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 15% year on year to $474 million. Its non-GAAP profit of $0.97 per share was 6.2% above analysts’ consensus estimates.
Hillman (NASDAQ:HLMN) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Hardware products and merchandising solutions provider Hillman (NASDAQ:HLMN) missed Wall Street’s revenue expectations in Q4 CY2025 as sales rose 4.5% year on year to $365.1 million. The company’s full-year revenue guidance of $1.65 billion at the midpoint came in 1.9% below analysts’ estimates. Its non-GAAP profit of $0.10 per share was in line with analysts’ consensus estimates.
Watsco (NYSE:WSO) Misses Q4 CY2025 Sales Expectations
Equipment distributor Watsco (NYSE:WSO) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 10% year on year to $1.58 billion. Its GAAP profit of $1.68 per share was 11% below analysts’ consensus estimates.
NeoGenomics’s (NASDAQ:NEO) Q4 CY2025 Sales Beat Estimates
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.6% year on year to $190.2 million. The company expects the full year’s revenue to be around $797 million, close to analysts’ estimates. Its non-GAAP profit of $0.06 per share was $0.02 above analysts’ consensus estimates.
Valmont (NYSE:VMI) Misses Q4 CY2025 Sales Expectations
Infrastructure and agriculture equipment manufacturer Valmont Industries (NYSE:VMI) fell short of the market’s revenue expectations in Q4 CY2025, with sales flat year on year at $1.04 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.3 billion at the midpoint. Its GAAP profit of $9.05 per share was 83.1% above analysts’ consensus estimates.
Vulcan Materials (NYSE:VMC) Misses Q4 CY2025 Revenue Estimates, Stock Drops
Construction materials company Vulcan Materials (NYSE:VMC) fell short of the market’s revenue expectations in Q4 CY2025 as sales rose 3.2% year on year to $1.91 billion. Its non-GAAP profit of $1.70 per share was 19.5% below analysts’ consensus estimates.
Donnelley Financial Solutions (NYSE:DFIN) Surprises With Strong Q4 CY2025
Financial regulatory software provider Donnelley Financial Solutions (NYSE:DFIN) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 10.4% year on year to $172.5 million. On the other hand, next quarter’s revenue guidance of $205 million was less impressive, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.70 per share was 70.7% above analysts’ consensus estimates.
Genuine Parts (NYSE:GPC) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops
Auto and industrial parts retailer Genuine Parts (NYSE:GPC) fell short of the market’s revenue expectations in Q4 CY2025 as sales rose 4.1% year on year to $6.01 billion. Its non-GAAP profit of $1.55 per share was 14.8% below analysts’ consensus estimates.